The authors declare that they have no competing interests.
RI conceived the study, collaborated on the study design, patient recruitment, data analysis and manuscript preparation and review. EG collaborated on the study design, patient recruitment, data analysis and manuscript preparation and review. AP collaborated on data analysis, manuscript preparation and review. MDA collaborated on data analysis, manuscript preparation and review. UT conceived the study, participated in its design and coordination and collaborated on patient recruitment, data analysis and manuscript preparation and review. All authors read and approved the final manuscript.
Reduction of tibial plateau fractures and maintain a level of well aligned congruent joint is key to a satisfactory clinical outcome and is important for the return to pre-trauma level of activity. Stable internal fixation support early mobility and weight bearing. The augmentation with bone graft substitute is often required to support the fixation to mantain reduction. For these reasons there has been development of novel bone graft substitutes for trauma applications and in particular synthetic materials based on calcium phosphates and/or apatite combined with calcium sulfates. Injectable bone substitutes can optimize the filling of irregular bone defects. The purpose of this study was to assess the potential of a novel injectable bone substitute CERAMENT™|BONE VOID FILLER in supporting the initial reduction and preserving alignment of the joint surface until fracture healing.
From June 2010 through May 2011 adult patients presenting with acute, closed and unstable tibial plateau fractures which required both grafting and internal fixation, were included in a prospective study with percutaneous or open reduction and internal fixation (ORIF) augmented with an injectable ceramic biphasic bone substitute CERAMENT™|BONE VOID FILLER (BONESUPPORT™, Lund, Sweden) to fill residual voids. Clinical follow up was performed at 1, 3, 9 and 12 months and any subsequent year; including radiographic analysis and Rasmussen system for knee functional grading.
Twenty four patients, balanced male-to-female, with a mean age of 47 years, were included and followed with an average of 44 months (range 41–52 months). Both Schatzker and Müller classifications were used and was type II or 41-B3 in 7 patients, type III or 41-B2 in 12 patients, type IV or 41-C1 in 2 patients and type VI or 41-C3 in 3 patients, respectively. The joint alignement was satisfactory and manteined within a range of 2 mm, with an average of 1.18 mm. The mean Rasmussen knee function score was 26.5, with 14 patients having an excellent result and the remaining 10 with a good result.
It can be concluded that radiological and clinical outcome was satisfactory and obtained in all cases without complications. This injectable novel biphasic hydroxyapatite and calcium sulfate ceramic material is a valuable armamentarium in the treatment of trauma where bone graft is required.
Blokker CP, Rorabeck CH, Bourne RB. Tibial plateau fractures: an analysis of the results of treatment in 60 patients. Clin Orthop Relat Res. 1984;182:193–9. PubMed
Faour O, Dimitriou R, Cousins CA, Giannoudis PV. The use of bone graft substitutes in large cancellous voids: any specific needs? Injury. 2011;42 Suppl 2:87–90. CrossRef
Rasmussen PS. Tibial condylar fractures: impairment of knee joint stability as an indication for surgical treatment. J Bone Joint Surg Am. 1973;55:1331–50. PubMed
Schatzker J, McBroom R, Bruce D. The tibial plateau fracture. The Toronto experience 1968–1975. Clin Orthop Relat Res. 1979;138:94–104. PubMed
Kellam JF, Audige L. Fracture Classification. In: Ruedi JP, editor. AO Principles of Fracture Management. 2nd ed. Switzerland: AO Publishing; 2007. p. 69–86.
Ozturkman Y, Caniklioglu M, Karamehmetoglu M, Sükür E. Calcium phosphate augmentation in the treatment of depressed tibial plateau fractures with open reduction and internal fixation. Acta Orthop Traumatol Turc. 2010;44:262–9. CrossRef
Bucholz RW, Carlton A, Holmes R. Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop Relat Res. 1989;240:53–62. PubMed
Larsson S, Hannink G. Injectable bone-graft substitutes: current products, their characteristics and indications and new developments. Injury. 2011;42 Suppl 2:30–4. CrossRef
Abramo A, Geijer M, Kopylov P, Tägil M. Osteotomy of distal radius fracture malunion using a fast remodeling bone substitute consisting of calcium sulfate and calcium phosphate. J Biomed Mat Res B Applied Biomaterials. 2010;92:281–6. CrossRef
- Augmentation of tibial plateau fractures with an injectable bone substitute: CERAMENT™. Three year follow-up from a prospective study
- BioMed Central
Neu im Fachgebiet Orthopädie und Unfallchirurgie
Mail Icon II